GLP-1 receptor agonists (GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their attributes such as body weight loss, protection of islet cells, promotion of islet cell proliferation and minimal side effects
Praharaj PP, Panigrahi DP, Bhol CS, Patra S, Mishra SR, Mahapatra KK, et al
Saxenda for weight management), and exenatide (Byetta, Bydureon for diabetes), though local availability may vary
[PMID: 2674034] PubMed record related to this compound for laboratory literature review
The validation dataset contains peptide identifiers (pep_ID), amino acid sequences, experimentally determined EC50 values in picomolar units (pM) for GCGR, GLP1R, and GIPR receptors, corresponding log-transformed EC50 values, and source publications
Stay Social With Us